• Study objective of increasing percentage of patients reaching PFS6 by 100% was substantially exceeded
• No drug-related adverse effects observed
• All existing investors participated in this financing round
• Clinical proof-of-concept data with APG101 expected in Q1/2012
• Grant secures execution of work packages necessary for a phase II trial
with patients suffering from myelodysplastic syndromes (MDS)
• Phase II trial for the treatment of MDS planned in 2013
Glycotope GmbH, a global leader in optimizing the glycosylation of biopharmaceuticals, has received the prestigious CPhI Innovation Gold Award
Das Europäische Gateway ”www.toolsofscience.eu” wurde heute mit Einträgen aus 13 europäischen Bioregionen erstmals der Öffentlichkeit zugänglich gemacht
Displaying results 21 to 25 out of 134
< Previous
1
2
3
4
5
6
7
Next >
Imprint 
Contact Us 
